Thomas J. Tisch serves as Executive at SYNAGEVA BIOPHARMA CORP, where they oversee executive responsibilities. Since joining the company, Thomas J. Tisch has executed 12 insider transactions totaling $53.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 10, 2017 involved transacting 26,006 shares valued at $0.
Thomas J. Tisch currently holds 26,006 shares of SYNAGEVA BIOPHARMA CORP (GEVA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas J. Tisch has been a net buyer of GEVA stock. They have purchased $53.2M and sold $0 worth of shares.
Thomas J. Tisch's most recent insider trade was on Jan 10, 2017, when they sold 26,006 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 10, 2017 | SHLD | $0 | Other | 113,185 | $N/A | Discretionary |
| Jun 22, 2015 | GEVA | $0 | Disposition | 373,560 | $N/A | Discretionary |
| Jun 22, 2015 | GEVA | $0 | Disposition | 378,435 | $N/A | Discretionary |
| Apr 16, 2014 | SHLD | $3.3M | Purchase | 100,000 | $33.40 | Discretionary |
| Apr 15, 2014 | SHLD | $12.6M | Purchase | 375,000 | $33.60 | Discretionary |
| Jan 9, 2013 | GEVA | $1000.0K | Purchase | 21,039 | $47.53 | Discretionary |
| Jul 12, 2012 | GEVA | $1.5M | Purchase | 36,500 | $41.20 | Discretionary |
| Jul 12, 2012 | GEVA | $1.5M | Purchase | 36,500 | $41.20 | Discretionary |
| Jan 10, 2012 | GEVA | $30.2M | Purchase | 1,200,000 | $25.18 | Discretionary |
| Jan 10, 2012 | GEVA | $3.0M | Purchase | 120,000 | $25.18 | Discretionary |